{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:10:05Z","timestamp":1759338605802,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.revmed.2012.10.376","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T20:48:14Z","timestamp":1354222094000},"page":"110-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cholangite scl\u00e9rosante de r\u00e9animation\u00a0: \u00e9volution favorable sous acide ursod\u00e9soxycholique et f\u00e9nofibrate"],"prefix":"10.1016","volume":"34","author":[{"given":"P.","family":"B\u00e9l\u00e9notti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guervilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Grandval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Benyamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Serratrice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Laugier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Papazian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-J.","family":"Weiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.10.376_bib0005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gut.52.5.688","article-title":"Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders","volume":"52","author":"Engler","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2012.10.376_bib0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00535-006-1831-0","article-title":"Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels","volume":"41","author":"Kita","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1572-0241.2002.05869.x","article-title":"Beneficial effect of bezafibrate on primary sclerosing cholangitis","volume":"97","author":"Kita","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0020","first-page":"170","article-title":"A case of primary sclerosing cholangitis presenting transient hypoperfusion and treated with bezafibrate beneficially","volume":"99","author":"Kita","year":"2002","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.revmed.2012.10.376_bib0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00535-010-0204-x","article-title":"Bezafibrate for the treatment of primary sclerosing cholangitis","volume":"45","author":"Mizuno","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1572-0241.2007.01118.x","article-title":"Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients","volume":"102","author":"Gelbmann","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00535-004-1518-3","article-title":"Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis","volume":"40","author":"Akbar","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00365521.2010.537683","article-title":"Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation","volume":"46","author":"Kirchner Gl","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.annfar.2008.04.019","article-title":"Ischaemic cholestasis in intensive care unit","volume":"27","author":"Beaussier","year":"2008","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.revmed.2012.10.376_bib0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.hepres.2004.04.001","article-title":"Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis","volume":"29","author":"Itakura","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.revmed.2012.10.376_bib0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MCG.0b013e3181c115b3","article-title":"Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid","volume":"44","author":"Hazzan","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.revmed.2012.10.376_bib0060","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/bmt.2009.251","article-title":"Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation","volume":"45","author":"Hidaka","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2012.10.376_bib0065","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1194\/jlr.M400132-JLR200","article-title":"Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2\u00a0cells by PPARalpha-mediated redistribution of ABCB4","volume":"45","author":"Shoda","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.revmed.2012.10.376_bib0070","first-page":"643","article-title":"Bezafibrate alone is an effective first-line therapy for primary sclerosing cholangitis: a case report","volume":"103","author":"Gondoh","year":"2006","journal-title":"Nihon Shokakibyo Gakkai Zasshi"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312011162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312011162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:57Z","timestamp":1759336257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866312011162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0248866312011162"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.10.376","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangite scl\u00e9rosante de r\u00e9animation\u00a0: \u00e9volution favorable sous acide ursod\u00e9soxycholique et f\u00e9nofibrate","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.10.376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}